Insider activities archive   |   Recent insider buys   |   Top 10 insider buys   |   Privacy



Stock Trading History of Manyak David M

The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Manyak David M since year 2005. The trader's CIK number is 1342137. At the time of this reporting, Manyak David M is the Exec VP, Drug Discovery Svcs of Caliper Life Sciences Inc . (stock ticker symbol CALP). See this page for all insider trading activities at Caliper Life Sciences Inc .

Stock purchases, sales, and option exercises reported by insider Manyak David M since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2008-03-14 CALP Caliper Life Sciences Inc Sale 4,700 4.11 19,337
2007-12-20 CALP Caliper Life Sciences Inc Sale 1,720 5.50 9,460
2007-12-17 CALP Caliper Life Sciences Inc Sale 6,500 5.63 36,625
2007-12-19 CALP Caliper Life Sciences Inc Sale 780 5.53 4,310
2007-12-10 CALP Caliper Life Sciences Inc Sale 9,000 5.81 52,280
2007-12-03 CALP Caliper Life Sciences Inc Sale 17,849 5.52 98,615
2007-11-30 CALP Caliper Life Sciences Inc Sale 18,151 5.59 101,418
2007-11-05 CALP Caliper Life Sciences Inc Sale 9,000 5.72 51,492
2007-10-29 CALP Caliper Life Sciences Inc Sale 9,000 5.88 52,944
2007-10-22 CALP Caliper Life Sciences Inc Sale 9,000 5.80 52,238
2007-10-15 CALP Caliper Life Sciences Inc Sale 9,000 6.02 54,135
2007-09-14 CALP Caliper Life Sciences Inc Sale 2,000 5.42 10,840
2007-09-07 CALP Caliper Life Sciences Inc Sale 1,680 5.65 9,492
2006-11-28 CALP Caliper Life Sciences Inc Sale 41,118 5.52 227,176
2006-11-30 CALP Caliper Life Sciences Inc Sale 8,882 5.53 49,117
2006-03-14 CALP Caliper Life Sciences Inc Sale 50,000 6.57 328,500

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Manyak David M (Exec VP, Drug Discovery Svcs of Caliper Life Sciences Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.

© 2005-2008, insider-monitor.com. All rights reserved.